Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease

NeuroImage

Volumn 39, Issue 3, 2008, Pages 1034-1040

  Whitwell, Jennifer L ^a   Jack Jr , Clifford R ^a   Pankratz, V Shane ^a   Parisi, Joseph E ^a   Knopman, David S ^a   Boeve, Bradley F ^a   Petersen, Ronald C ^a   Dickson, Dennis W ^b   Josephs, Keith A ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN;

AGED; ALZHEIMER DISEASE; APPARATUS; ARTICLE; AUTOPSY; BRAIN ATROPHY; BRAIN DEGENERATION; BRAIN VENTRICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING SUM OF BOXES; FEMALE; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN IMMUNOREACTIVE CHANGES; HUMAN; IMMUNOREACTIVITY; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SAMPLE SIZE; SCORING SYSTEM; TIME;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; AUTOPSY; BRAIN; CEREBRAL VENTRICLES; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 37849017699     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.10.001     Document Type: Article

References (29)

1. Boccardi M., Laakso M.P., Bresciani L., Galluzzi S., Geroldi C., Beltramello A., Soininen H., and Frisoni G.B. The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia. Neurobiol. Aging 24 (2003) 95-103
2. Braak H., and Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta. Neurol. Scand. Suppl. 165 (1996) 3-12
3. Broe M., Hodges J.R., Schofield E., Shepherd C.E., Kril J.J., and Halliday G.M. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 60 (2003) 1005-1011
4. Chan D., Fox N.C., Jenkins R., Scahill R.I., Crum W.R., and Rossor M.N. Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. Neurology 57 (2001) 1756-1763
5. Chan D., Janssen J.C., Whitwell J.L., Watt H.C., Jenkins R., Frost C., Rossor M.N., and Fox N.C. Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet 362 (2003) 1121-1122
6. Ezekiel F., Chao L., Kornak J., Du A.T., Cardenas V., Truran D., Jagust W., Chui H., Miller B., Yaffe K., Schuff N., and Weiner M. Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: boundary shift integral versus tracing of the entorhinal cortex and hippocampus. Alzheimer Dis. Assoc. Disord. 18 (2004) 196-201
7. Fox N.C., and Freeborough P.A. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J. Magn. Reson. Imaging 7 (1997) 1069-1075
8. Fox N.C., Black R.S., Gilman S., Rossor M.N., Griffith S.G., Jenkins L., and Koller M. Effects of A{beta} immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 64 (2005) 1563-1572
9. Freeborough P.A., and Fox N.C. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans. Med. Imaging 16 (1997) 623-629
10. Freeborough P.A., Fox N.C., and Kitney R.I. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput. Methods Programs Biomed. 53 (1997) 15-25
11. Gunter J.L., Shiung M.M., Manduca A., and Jack Jr. C.R. Methodological considerations for measuring rates of brain atrophy. J. Magn. Reson. Imaging 18 (2003) 16-24
12. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 140 (1982) 566-572
13. Jack Jr. C.R., Slomkowski M., Gracon S., Hoover T.M., Felmlee J.P., Stewart K., Xu Y., Shiung M., O'Brien P.C., Cha R., Knopman D., and Petersen R.C. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 60 (2003) 253-260
14. Jack Jr. C.R., Shiung M.M., Gunter J.L., O'Brien P.C., Weigand S.D., Knopman D.S., Boeve B.F., Ivnik R.J., Smith G.E., Cha R.H., Tangalos E.G., and Petersen R.C. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62 (2004) 591-600
15. Josephs K.A., Holton J.L., Rossor M.N., Godbolt A.K., Ozawa T., Strand K., Khan N., Al-Sarraj S., and Revesz T. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol. Appl. Neurobiol. 30 (2004) 369-373
16. Josephs K.A., Parisi J.E., Knopman D.S., Boeve B.F., Petersen R.C., and Dickson D.W. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. Arch. Neurol. 63 (2006) 506-512
17. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
18. McKhann G.M., Albert M.S., Grossman M., Miller B., Dickson D., and Trojanowski J.Q. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch. Neurol. 58 (2001) 1803-1809
19. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
20. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P.H., Albert M., Boone K., Miller B.L., Cummings J., and Benson D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51 (1998) 1546-1554
21. NIA. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol. Aging 18 (1997) S1-S2
22. Ridha B.H., Barnes J., Bartlett J.W., Godbolt A., Pepple T., Rossor M.N., and Fox N.C. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol. 5 (2006) 828-834
23. Schott J.M., Price S.L., Frost C., Whitwell J.L., Rossor M.N., and Fox N.C. Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology 65 (2005) 119-124
24. Schott J.M., Frost C., Whitwell J.L., Macmanus D.G., Boyes R.G., Rossor M.N., and Fox N.C. Combining short interval MRI in Alzheimer's disease: implications for therapeutic trials. J. Neurol. 253 (2006) 1147-1153
25. Sled J.G., Zijdenbos A.P., and Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 17 (1998) 87-97
26. Uchikado H., Lin W.L., DeLucia M.W., and Dickson D.W. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J. Neuropathol. Exp. Neurol. 65 (2006) 685-697
27. Wang D., Chalk J.B., Rose S.E., de Zubicaray G., Cowin G., Galloway G.J., Barnes D., Spooner D., Doddrell D.M., and Semple J. MR image-based measurement of rates of change in volumes of brain structures: Part II. Application to a study of Alzheimer's disease and normal aging. Magn. Reson. Imaging 20 (2002) 41-48
28. Whitwell J.L., Crum W.R., Watt H.C., and Fox N.C. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am. J. Neuroradiol. 22 (2001) 1483-1489
29. Whitwell J.L., Jack Jr. C.R., Parisi J.E., Knopman D.S., Boeve B.F., Petersen R.C., Ferman T.J., Dickson D.W., and Josephs K.A. Rates of cerebral atrophy differ in different degenerative pathologies. Brain 130 (2007) 1148-1158